Today: 1 May 2026
Dow Jones drops 400 points as Goldman, Caterpillar slide and Intel jitters linger

Dow Jones drops 400 points as Goldman, Caterpillar slide and Intel jitters linger

New York, January 23, 2026, 13:37 EST — Regular session

The Dow Jones Industrial Average dropped 411 points, or 0.8%, Friday afternoon, dragged lower by steep losses in Goldman Sachs and Caterpillar. American Express, JPMorgan Chase, and Walt Disney also pulled the blue-chip index down.

The Dow slipped, even as the S&P 500 and Nasdaq eked out small gains, buoyed by renewed interest in mega-cap tech. But Intel’s sharp drop and tariff worries kept traders on edge. “Some of these AI stocks have been inflated dramatically,” said Joe Saluzzi, partner and co-founder at Themis Trading, noting investors want “real plans” behind the hype. The Federal Reserve is widely expected to keep rates steady next week, with Apple, Tesla, and Microsoft—all part of the “Magnificent Seven”—set to report earnings. Investing.com

Intel’s guidance hit the market hard. The chipmaker projected first-quarter revenue between $11.7 billion and $12.7 billion, with adjusted earnings expected to break even—both figures falling short of Wall Street’s forecasts. Executives flagged difficulties in keeping up with demand for server CPUs powering AI data centers. CEO Lip-Bu Tan admitted he was “disappointed” the company couldn’t fully satisfy the surge, while CFO David Zinsner said customers were “caught off guard” by how rapidly demand escalated. Reuters

U.S. consumer sentiment edged up in January but remained over 20% lower compared to last year, held back by concerns over high prices and a weaker labor market. Inflation expectations for the next year fell to 4.0%, marking their lowest point since January 2025.

A separate survey indicated U.S. business activity stayed steady earlier this month, despite firms facing persistent price pressures partly linked to tariffs. S&P Global’s “flash” PMI — an early snapshot from monthly business surveys — remained in expansion territory, with price gauges staying high. Reuters

Demand for safe-haven assets remained strong. Silver cracked the $100 an ounce mark, while gold hovered close to record highs. BNP Paribas strategist David Wilson warned that “profit taking” following the late-2025 rally is “likely sooner rather than later.” Investing.com

Thursday brought a shift in sentiment. The Dow rose 306.78 points to close at 49,384.01 after President Donald Trump pulled back from tariff threats related to Greenland, fueling a bounce back from earlier losses in the week. “It’s very weird to wake up every day,” said Gregg Abella, CEO of Investment Partners Asset Management, likening the mood swings to “Christmas morning or Friday the 13th.” Reuters

Here’s a key detail for traders: the Dow is a price-weighted index. That means stocks with higher prices impact the average more than those with lower prices, no matter the company’s size. Its level gets calculated by a divisor, which gets tweaked to account for corporate moves like stock splits.

The downside risk remains clear. Another round of tariff hikes could weigh on cyclical Dow stocks once more, and a disappointing earnings report from major tech firms or a fresh AI setback might dampen overall risk appetite.

The Fed’s next major event is its two-day policy meeting wrapping up January 28. The decision drops at 2:00 p.m. ET, followed by the chair’s press conference at 2:30 p.m. ET.

Stock Market Today

  • Seaport Therapeutics Upsizes IPO to $255M, CEO Highlights New Biotech Pathway
    May 1, 2026, 2:02 PM EDT. Seaport Therapeutics raised $254.9 million in an upsized Nasdaq IPO, exceeding initial $180 million estimates. CEO Daphne Zohar highlighted a shift from traditional M&A (mergers and acquisitions) to public offerings, reflecting confidence in developing and marketing their depression drug pipeline independently. The company may raise an additional $38.2 million through underwriters' option. Zohar pointed to industry changes where biotech firms are now focusing on advancing medicines directly to patients, citing success stories like Karuna Therapeutics and Intra-Cellular Therapies. Seaport's board recently welcomed Sharon Mates, who led Intra-Cellular to a $1.5 billion drug launch before its J&J acquisition. This IPO signals renewals in the biotech public market despite recent Big Pharma dealmaking.

Latest article

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

1 May 2026
The Dow Jones Industrial Average fell 78.72 points to 49,573.42 by midday Friday, reversing an early rally as tariff concerns weighed on gains from Apple and other strong earnings reports. President Donald Trump announced a 25% tariff on EU-made cars and trucks starting next week. Apple reported quarterly revenue of $111.2 billion, up 17% year over year. Oil prices dropped after Iran sent a new negotiation proposal.
US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

1 May 2026
The S&P 500 rose 0.48% and the Nasdaq 0.96% to record highs Friday, while the Dow slipped 0.11%. Apple shares climbed after reporting its strongest quarterly sales growth in over four years. Atlassian and other software stocks rallied on strong cloud demand. Exxon and Chevron beat profit estimates but cited pressure from Middle East conflict and volatile oil prices.
Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

1 May 2026
Recursion Pharmaceuticals said founder and board chair Chris Gibson will not seek re-election at the June 17 annual meeting, months after stepping down as CEO. The company reports first-quarter results May 6, with investors watching for updates on cash, clinical progress, and its AI drug platform. Recursion last reported $753.9 million in cash and narrowed its quarterly net loss. Gibson will remain chair until his term ends.
IREN stock jumps nearly 9% as new 2x short ETF hits tape and Feb. 5 earnings loom
Previous Story

IREN stock jumps nearly 9% as new 2x short ETF hits tape and Feb. 5 earnings loom

Gold price nears $5,000 again as banks lift forecasts; traders eye Fed next week
Next Story

Gold price nears $5,000 again as banks lift forecasts; traders eye Fed next week

Go toTop